ESPE Abstracts (2016) 86 P-P1-5

ESPE2016 Poster Presentations Adrenal P1 (48 abstracts)

Whole Exome Sequencing in Patients with Primary Generalized Glucocorticoid Resistance, who did not have Mutations in the NR3C1 Gene

Amalia Sertedaki a , Alexandros Polyzos c , Nicolas Nicolaides a, , Dimitris Thanos c & Evangelia Charmandari a,

aDivision of Endocrinology, Metabolism and Diabetes, First Department of Pediatrics, University of Athens Medical School, ‘Aghia Sophia’ Children’s Hospital, Athens, Greece; bDivision of Endocrinology and Metabolism, Biomedical Research Foundation of the Academy of Athens, Athens, Greece; cInstitute of Molecular Biology, Genetics and Biotechnology, Biomedical Research Foundation of the Academy of Athens, Athens, Greece

Background: Primary generalized glucocorticoid resistance (PGGR) is a rare, familial or sporadic condition, characterized by generalized, partial tissue insensitivity to glucocorticoids. The molecular basis of this condition has been ascribed to mutations in the NR3C1 (human glucocorticoid receptor, hGR) gene, which impair the molecular mechanisms of hGR action and decrease tissue sensitivity to glucocorticoids. However, a considerable number of patients with PGGR do not have mutations in the NR3C1 gene.

Objective and hypotheses: Using whole exome sequencing, we investigated whether other genes are implicated in the pathogenesis of PGGR.

Method: Ten adult patients (age range: 18–48 years; 6 males, 4 females) with PGGR, who did not have mutations in the NR3C1 following Sanger sequencing and two patients with PGGR harbouring known mutations of the NR3C1 gene (positive controls) underwent whole exome sequencing on an Ion Proton platform (ThermoFisher Scientific USA).

Results: Each exome sequence revealed the presence of approximately 55 000 variants. Using a cut off value of 100 reads/variant, a total number of 507 non-synonymous and frameshift mutations were detected in all patients. These mutations corresponded to 390 genes involved in five different pathways, one of which was that of steroid hormone biosynthesis (CYP1B1, CYP3A7, AKR1C4, UGT2A3). Nineteen of the 390 genes were found to be regulated directly by TP53 possibly indicating the presence of a cascade. One mutation of the GP6 gene present in all patients was not annotated. The presence of mutations in the genes HSP90AA1, NCOA1, SMARCA4, NCOA2, JUN, UBC, CREBBP, NFKB1, RELA and NCOA3 (functional partners of the NR3C1 after searching the STRING database) was examined and no pathogenic variants were detected.

Conclusion: Whole exome sequencing may allow us to expand the spectrum of genes associated with PGGR. Further bioinformatic analysis is required to establish pathogenic variants in genes related to this condition.

Article tools

My recent searches

No recent searches.